THERAPEUTIC BENEFIT OF ADJUVANT GEMCITABINE-CISPLATIN COMBINATION CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH INVASIVE TRANSITIONAL CELL CARCINOMA OF THE UPPER URINARY TRACT

✍ Scribed by Y.S. Song; S.H. Doo; J.H. Yun; W.J. Yang; C.I. Kim; H.S. Kim; K.H. Song; S.I. Kim; S.J. Kim; D.H. Lee; I.R. Cho; D.H. Seong; J.S. Cho; Y.S. Kim; S.H. Chun; D.J. Kim; B.H. Chung; K.S. Cho; Y.D. Choi; S.J. Hong

• Book ID: 119618928
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 71 KB
• Volume: 7
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/s1569-9056(08)60598-9